We’re heading to Montreal for #CUA2023! Go to our booth #60 to chat with Robert Paproski, Desmond Pink, Colin Coros, and Catalina Vasquez about ClarityDX Prostate, a risk score to predict aggressive prostate cancer.
Dr. Adam Kinnaird will be moderating an e-poster, “Clinical validation of optimized neural network risk models to predict grade group 2 and above prostate cancer and avoid unneeded biopsies”.
Go here to view the poster and post questions, CUA 2023 e-Poster.
Session 9 Oncology (Prostate – Part 2)
Room: Joyce (Level A), 2023-06-25 at 7:35:00
#diagnostics #prostatecancer #machinelearningalgorithms
